Degarelix, a novel GnRH antagonist, causes minimal histamine release compared with cetrorelix, abarelix and ganirelix in an ex vivo model of human skin samples-Reference-Cited by-同舟云学术

Degarelix, a novel GnRH antagonist, causes minimal histamine release compared with cetrorelix, abarelix and ganirelix in an ex vivo model of human skin samples

Published:2010-09-14 Issue:4 Volume:70 Page:580-587
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Koechling Wolfgang,Hjortkjaer Rolf,Tankó László B.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2010.03730.x/fullpdf

Reference22 articles.

1. History and classification of anaphylaxis;Ring;Novartis Found Symp,2004

2. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells;Veien;Anesthesiology,2000

3. Single-dose administration of the gonadotropin-releasing hormone antagonist, Nal-Lys (antide) to healthy men;Bagatell;Fertil Steril,1993

4. Dose effects of the gonadotropin-releasing hormone antagonist, Nal-Glu, combined with testosterone enanthate on gonadotropin levels in normal men;Bagatell;Fertil Steril,1995

5. GnRH antagonists;Coccia;Eur J Obstet Gynecol Reprod Biol,2004

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone receptor antagonist, in healthy men: a randomized, double-blind, placebo-controlled phase 1 study;BMC Medicine;2023-04-03

2. A review of clinical evidence to assess differences in efficacy and safety of luteinizing hormone–releasing hormone (LHRH) agonist (goserelin) and LHRH antagonist (degarelix);Indian Journal of Cancer;2022

3. Relugolix, an oral gonadotropin-releasing hormone antagonist for the treatment of prostate cancer;Future Oncology;2021-11

4. The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data;CJC Open;2021-10

5. Hydrophilic interaction chromatography for the analysis of biopharmaceutical drugs and therapeutic peptides: A review based on the separation characteristics of the hydrophilic interaction chromatography phases;Journal of Separation Science;2019-01